NCT07378098: to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
- State
- Under way
- Phase
- Phase 3
- People
- 254 planned
- Started
- 3 Feb 2026
- Primary completion
- 31 Mar 2028
- Arms
- KLH-2109+ Leurprorelin acetate Placebo
- Results
- None posted
- 30 Jan 2026: Trial registered
- 3 Feb 2026: Trial started